Correlation of Serum FGF23 and Chronic Kidney Disease-Mineral and Bone Abnormality Markers With Cardiac Structure Changes in Maintenance Hemodialysis Patients
Table 5
The comparison of clinical cardiac ultrasound parameters among different FGF23 concentration groups.
Parameters (cardiac ultrasound)
Group 1 N = 26
Group 2 N = 25
Group 3 N = 27
Group 4 N = 29
value
(3.75–172.03)
(182.13–1146.13)
(1186.17–6314.80)
(6438.10–14610.14)
LVE n (%)
6 (23.0%)
7 (28.0%)
5 (18.5%)
7 (24.1%)
0.881
RAE n (%)
15 (57.6%)
17 (68.0%)
22 (81.4%)
13 (44.8%)
0.035
LEH n (%)
15 (57.6%)
13 (52.0%)
19 (70.3%)
13 (44.8%)
0.27
Valvular stenosis n (%)
14 (53.8%)
10 (40%)
15 (55.5%)
10 (34.4%)
0.315
LVEF (%)
64.11 ± 10.97
65.28 ± 14.19
64.51 ± 9.01
64.63 ± 10.76
0.985
Note. LVE: left ventricular enlargement; RAE: right atrial enlargement; LVH: left ventricular hypertrophy; and LVEF: left ventricular ejection fraction. Boldface represents .
